Citation

Hyman SE. 1993. Molecular and cell biology of addiction. Current opinion in neurology and neurosurgery. 6(4):609-13. Pubmed: 8400475

Abstract

Progress was made during the past year in several important areas relevant to cellular and molecular research on addiction. This includes a better understanding of the functioning of neural circuitry involved in the reinforcing properties of drugs of abuse, the cloning of complementary DNA's encoding important molecular targets of addictive drugs, including the first opiate receptors to be cloned, and progress in understanding the molecular basis of adaptive processes underlying dependence and withdrawal.

Related Faculty

Photo of Steven Hyman

Steven Hyman is Director of the Stanley Center for Psychiatric Research at the Broad Institute and Chair of the Schizophrenia Spectrum Biomarkers Consortium (SSBC), a consortium identifying objective biomarkers to enable better diagnosis of and treatment for schizophrenia and related illnesses.

Search Menu